Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes

References

• Abdel-Hamid M. E., Abuirjeie M. A. Determination of diazepam and oxazepam using high-performance liquid chromatography and fourth-derivative spectrophotometric techniques. Analyst 1988; 113: 1443–1446
   PubMed Web of Science ®Google Scholar
• Aoyama T., Gelboin H. V., Gonzalez F. J. Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline by complementary DNA-expressed human liver P-450. Cancer Research 1990b; 50: 2060–2063
   PubMed Web of Science ®Google Scholar
• Aoyama T., Yamano S., Guzelian P. S., Gelboin H. V., Gonzalez F. J. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically active aflatoxin B1. Proceedings of the National Academy of Sciences, USA 1990a; 87: 4790–4793
   PubMed Web of Science ®Google Scholar
• Birkett D. J., Mackenzie P. I., Veronese M. E., Miners J. O. In vitro approaches can predict human drug metabolism. Trends in Pharmacological Sciences 1993; 14: 292–294
   PubMed Web of Science ®Google Scholar
• Chen L. -S., Yasumori T., Yamazoe Y., Kato R. Hepatic microsomal tolbutamide hydroxylation in Japanese: in vitro evidence for rapid and slow metabolizers. Pharmacogenetics 1993; 3: 77–85
   PubMedGoogle Scholar
• Clejan L. A., Cederbaum A. I. Role of iron, hydrogen peroxide and reactive species in microsomal oxidation of glycerol to formaldehyde. Archives in Biochemistry and Biophysics 1991; 285: 83–89
   PubMed Web of Science ®Google Scholar
• Clejan L. A., Cederbaum A. I. Structural determinations for alcohol substrates to be oxidized to formaldehyde by rat liver microsomes. Archives in Biochemistry and Biophysics 1992; 298: 105–113
   PubMedGoogle Scholar
• Crespi C. L., Penman B. W., Leakey J. A. E., Arlotto M. P., Stark A., Parkinson A., Turner T., Steimel D., Rudo K., Davies R. L., Langenbach R. Human cytochrome P450IIA3 cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 1990; 11: 1293–1300
   PubMed Web of Science ®Google Scholar
• Doecke C. J., Samson L. N., McManus M. E. Phenytoin 4-hydroxylation by rabbit liver P450IIC3 and identification of orthologs in human liver microsomes. Biochemical and Biophysical Research Communications 1990; 166: 860–866
   PubMed Web of Science ®Google Scholar
• Forrester L. M., Henderson C. J., Glancey M. J., Back D. J., Park B. K., Ball S. E., Kitteringham N. R., McLaren A. W., Miles J. S., Skett P., Wolf C. R. Relative expression of cytochrome P450 isozymes in human liver and association with the metabolism of drugs and xenobiotics. Biochemical Journal 1992; 281: 359–368
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J., Aoyama T., Gelboin H. V. Expression of mammalian cytochrome P450 using vaccinia virus. Methods in Enzymology, M. R. Waterman, E. F. Johnson. Academic, San Diego 1991; 85–92, 206
   Google Scholar
• Grant D. M., Campbell M. E., Tang B. K., Kalow W. Biotransformation of caffeine by microsomes from human liver. Biochemical Pharmacology 1987; 36: 1251–1260
   PubMed Web of Science ®Google Scholar
• Grant M. H., Duthie S. J., Gray A. G., Byrke M. D. Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. Biochemical Pharmacology 1988; 21: 4111–4116
   Google Scholar
• Guengerich F. P. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicology Letters 1994; 70: 133–138
   PubMed Web of Science ®Google Scholar
• Hakkola J., Pasanen M., Purkunen R., Saarikoski S., Pelkonen O., Mäenpää J., Rane A., Raunio H. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochemical Pharmacology 1994; 48: 59–64
   PubMed Web of Science ®Google Scholar
• Halpert J. R., Guengerich F. P., Bend J. R., Correia M. A. Selective inhibitors of Cytochromes P450. Toxicology and Applied Pharmacology 1994; 125: 163–175
   PubMed Web of Science ®Google Scholar
• Imai Y., Ito A., Sato R. Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. Journal of Biochemistry 1966; 60: 417–428
   PubMed Web of Science ®Google Scholar
• Imaoka S., Terano Y., Funae Y. Expression of four phenobarbital-inducible cytochrome P-450s in liver, kidney, and lung of rats. Journal of Biochemistry 1989; 105: 939–945
   PubMed Web of Science ®Google Scholar
• Kamataki T., Maeda K., Yamazoe Y., Nagai T., Kato R. Sex-difference of cytochrome P-450 in the rat: purification, characterization, and quantification of constitutive forms of cytochrome P-450 from liver microsomes of male and female rats. Archives of Biochemistry and Biophysics 1983; 225: 758–770
   PubMed Web of Science ®Google Scholar
• Kato R., Yamazoe Y. The importance of substrate concentration in determining cytochromes P450 therapeutically relevant in vivo. Pharmacogenetics 1994; 4: 359–362
   PubMedGoogle Scholar
• Kimura S., Pastewka J., Gelboin H. V., Gonzalez F. J. cDNA and amino acid sequences of two members of the human IIC gene subfamily. Nucleic Acids Research 1987; 15: 10053–10054
   PubMed Web of Science ®Google Scholar
• Kronbach T., Mathys D., Gut J., Catin T., Meyer U. A. High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextro-methorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Analytical Biochemistry 1987; 162: 24–32
   PubMedGoogle Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. L. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Matsubara T., Koike M., Touchi A., Tochino Y., Sugeno K. Quantitative determination of cytochrome P-450 in rat liver homogenate. Analytical Biochemistry 1976; 75: 596–603
   PubMed Web of Science ®Google Scholar
• Nagata K., Matsunaga T., Gillette J., Gelboin H. V., Gonzalez F. J. Rat testosterone 7α-hydroxylase. Isolation, sequence and expression of cDNA and its developmental regulation and induction by 3-methoxycholanthrene. Journal of Biological Chemistry 1987; 262: 2787–2793
   PubMed Web of Science ®Google Scholar
• Narimatsu S., Masubuchi Y., Hosokawa S., Ohmori S., Kitada M., Suzuki T. Involvement of a cytochrome P4502D subfamily in human liver microsomal bunitrolol 4-hydroxylation. Biological Pharmacology Bulletin 1994; 17: 803–807
   PubMedGoogle Scholar
• Newton D. J., Wang R. W., Lu A. Y. H. Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition 1995; 23: 154–158
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. Carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Ono S., Tsutsui M., Gonzalez F. J., Satoh T., Masubuchi Y., Horie T., Suzuki T., Narimatsu S. Oxidative metabolism of bunitrolol by complementary DNA-expressed human cytochrome P450 isozymes in a human bepatoroa cell line (Hep G2) using recombinant vaccinia virus. Pharmacogenetics 1995a; 5: 97–102
   PubMedGoogle Scholar
• Ono S., Hatanaka T., Hotta H., Tsutsui M., Satoh T., Gonzalez F. J. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 1995b; 5: 143–150
   PubMedGoogle Scholar
• Relling M. V., Aoyama T., Gonzalez F. J., Meyer U. A. Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. Journal of Pharmacology and Experimental Therapeutics 1990; 252: 442–447
   PubMed Web of Science ®Google Scholar
• Rettie A. E., Korzekwa K. R., Kunze K. L., Lawrence R. F., Eddy A. C., Aoyama T., Gelboin H. V., Gonzalez F. J., Trager W. F. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chemical Research and Toxicology 1992; 5: 54–59
   PubMed Web of Science ®Google Scholar
• Rettie A. E., Wienkers L. C., Gonzalez F. J., Trager W. F., Korzekwa K. R. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics 1994; 4: 39–42
   PubMedGoogle Scholar
• Rodrigues A. D. Use of in vitro human metabolism studies in drug development. Biochemical Pharmacology 1994; 48: 2147–2156
   PubMed Web of Science ®Google Scholar
• Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F. P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacological and Experimental Therapeutics 1994; 270: 414–423
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W., Birkitt D. J., Veronese M. E., McManus M. E., Tukey R. H., Quattrochi L. C., Gelboin H. V., Miners J. O. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Journal of Pharmacology and Experimental Therapeutics 1993; 265: 401–407
   PubMed Web of Science ®Google Scholar
• Tsyrlov I. B., Mikhailenko V. M., Gelboin H. V. Isozyme- and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochimica et Biophysica Acta 1994; 1205: 325–335
   PubMed Web of Science ®Google Scholar
• Tyndale R., Aoyama T., Broly F., Matsunaga T., Inaba T., Kalow W., Gelboin H. V., Meyer U. A., Gonzalez F. J. Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281 : possible association with the poor metabolizer phenotype. Pharmacogenetics 1991; 1: 26–32
   PubMedGoogle Scholar
• Wrighton S. A., Vandenbranden M., Stevens J. C., Shipley L. A., Ring B. J. In vitro methods for assessing human hepatic drug metabolism: their use in drug development. Drug Metabolism Reviews 1993; 25: 453–484
   PubMed Web of Science ®Google Scholar
• Yamano S., Aoyama T., McBride O. W., Hardwick J. P., Gelboin H. V., Gonzalez F. J. Human NADPH-P450 oxido-reductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7. Molecular Pharmacology 1989; 35: 83–88
   Google Scholar
• Yamano S., Tatsuno J., Gonzalez F. J. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 1990; 29: 1322–1329
   PubMed Web of Science ®Google Scholar
• Yasumori T., Murayama N., Yamazoe Y., Kato R. Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2. Clinical Pharmacology and Therapeutics 1990; 47: 313–322
   PubMed Web of Science ®Google Scholar